SAN DIEGO and IPSWICH, Mass., July 12, 2011 /PRNewswire/ -- Comprendia, leading developer of web 2.0 and social media tools for the life sciences, sponsored by molecular biology reagents provider New England Biolabs, Inc. (NEB), is introducing an online resource that will support epigenetics research. Epigenetics is a quickly growing field with important implications for oncology, neurology, metabolism and disease mechanisms. 'Engaging Epigenetics Experts' (E3) is an online community that will allow epigenetics researchers to more easily connect so they can leverage their collective, interdisciplinary knowledge in a way that has not been possible before.
E3 takes concepts that have popularized social media applications, like Facebook, to another level by utilizing research publications to connect epigenetics scientists. For example, E3 members can find a report about an interesting experiment and quickly engage with the author, saving valuable time and simplifying knowledge transfer. Traditionally, life science discussions have occurred through private email, one-on-one, local interactions, or at yearly conferences; the E3 interface facilitates these communications potentially in real time, and opens them up to the wider community through public forums.
Mary Canady, President of Comprendia said "We interviewed epigenetics researchers and learned that their most important need was more access to expertise with a technique or another discipline. E3 was designed to meet this need, using web 2.0 technologies, which allow them to interact more seamlessly than ever before."
The E3 application already contains 27,000 epigenetics publications from more than 1,000 researchers, as well as a list of experts curated from these publications. Scientists can search the publications by title, abstract, author
|SOURCE New England Biolabs|
Copyright©2010 PR Newswire.
All rights reserved